Business
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Hi, what are you looking for?
Jewish Business News
All posts tagged "TEVA PHARMACEUTICAL INDUSTRIES LIMITED"
Business
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Business
IBM has selected Israeli Teva Pharmaceutical Industries Ltd. as its first foundational life sciences partner for the Watson Health Cloud. Financial terms of the partnership...
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Business
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the...
Business
Teva is the first applicant to receive approval and will have market exclusivity for generic Axert until November.
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Erez Vigodman: Size isn't everything; it's important to be better.